Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
3
institutions
Market cap
$76.1B
265M shares
52-week range
$239.51 – $315.47
63% from low
Sector
HOSPITAL & MEDICAL SERVICE PLANS
Exchange
NYSE
CS
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
www.thecignagroup.comNo one on the platform currently holds CI.
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 228,493 | $61.0M |
| Renaissance Technologiesas of 2026-03-31 | 218,939 | $58.4M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-09-08 | $1.5600 | 2026-09-23 |
| 2026-06-04 | $1.5600 | 2026-06-18 |
| 2026-03-05 | $1.5600 | 2026-03-19 |
| 2025-12-04 | $1.5100 | 2025-12-18 |
| 2025-09-04 | $1.5100 | 2025-09-18 |
| 2025-06-03 | $1.5100 | 2025-06-18 |
| 2025-03-05 | $1.5100 | 2025-03-20 |
| 2024-12-04 | $1.4000 | 2024-12-19 |
| 2024-09-04 | $1.4000 | 2024-09-19 |
| 2024-06-04 | $1.4000 | 2024-06-20 |
No one on the platform has traded CI yet.
| 20,000 |
| $7.3M |
| 2024-03-05 | $1.4000 | 2024-03-21 |
| 2023-12-05 | $1.2300 | 2023-12-21 |
| Execution date | Ratio |
|---|---|
| 2007-06-05 | 3-for-1 |
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$CI RMTG’s balance sheet has positive equity. SDOT shows a ($58.4M) shareholders' deficit.
View on StockTwits ↗$TSLA $CI $BBBY $AAPL Is Elon in on ELTP? Rumor Elite's products are being used on ships. Too the Moon.
View on StockTwits ↗$CI Positive (89%): shares face upward price pressure because the quarterly beat and higher 2026 adjusted-earnings floor give investors a basis to raise forward earnings expectations. Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/84d5a5a0a8183109?utm_source=stocktwits&utm_medium=story_url
View on StockTwits ↗$CI (-4.4% pre) Cigna Earnings Beat Estimates but Guidance Boost Fails to Impress https://www.barrons.com/articles/cigna-earnings-stock-price-771bd56b?mod=goog_fin_scbar
View on StockTwits ↗$CI Q2 '26 Earnings Results & Recap The Cigna Group raised its 2026 outlook for consolidated adjusted income from operations to at least $30.45 per share, which includes the impact of expected future share repurchases and anticipated dividends.
View on StockTwits ↗$CI Hasn't collapsed but didn create any big shareholder value since middle of 2022 either. I have an alarm at 320$ to consider closing my position should we get there again in the next couple of months.
View on StockTwits ↗$CI Cigna Q2 2026 Earnings -Adj EPS $7.78 (Est $7.60) -Adj Rev $71.56B (Est $70.34B) Outlook FY Adj EPS At Least $30.45 (Est $30.41) -Outlook FY Cigna Healthcare Medical Care Ratio 83.7% To 84.7% (Est 83.97%) -Cigna Healthcare Medical Care Ratio 84.5% (Est 84.46%)
View on StockTwits ↗#earnings before the open on Thursday, July 30, 2026 https://www.earningswhispers.com/calendar $MA $VLO $BMY $CI $RACE
View on StockTwits ↗$CI reports before tomorrow open, and its post-earnings history looks more measured than explosive, so this has tended to be a quieter setup than a headline-driven one.
View on StockTwits ↗$tdoc $unh $ci https://finance.yahoo.com/healthcare/articles/teladoc-health-introduces-virtual-care-100000661.html
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $286.0B | +5.0% | $30.44 | $30.27–$30.63 | 9.5× | 11 |
| 2027 | $298.2B | +4.3% | $33.49 | $32.50–$34.21 | 8.6× | 15 |
| 2028 | $315.6B | +5.8% | $36.98 | $29.79–$44.17 | 7.8× | 10 |
| 2029 | $330.8B | +4.8% | $41.46 | $40.35–$42.44 | 6.9× | 4 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-30 | $7.60 | $7.78 | +2.4% |
| 2026-04-30 | $7.60 | $7.79 | +2.5% |
| 2026-02-05 | $7.88 | $8.08 | +2.5% |
| 2025-10-30 | $7.64 | $7.83 | +2.5% |
| 2025-07-31 | $7.16 | $7.20 | +0.6% |
| 2025-05-02 | $6.35 | $6.74 | +6.1% |
| 2025-01-30 | $7.84 | $6.64 | -15.3% |
| 2024-10-31 | $7.23 |
| $7.51 |
| +3.9% |
| $60.7B |
| — |
| CVSCVS Health Corp. | $105.22 | -0.66% | $134.3B | — |
| ELVElevance Health Inc. | $376.40 | +0.11% | $81.6B | — |
Source: Financial Modeling Prep · peers by sector/industry